The Valens Company Ltd. (OTCMKTS: VLNCF) is a global cannabis science company specializing in the production of high-purity cannabinoid extracts. Since its founding in 2015, the company has focused on advancing extraction technologies and developing a broad portfolio of premium products, including distillates, isolates, and formulated oils tailored for both medical and recreational markets.
Valens offers a white-label manufacturing platform that serves licensed producers, brand owners, and research institutions. The company’s core services encompass proprietary extraction processes, formulation expertise, and comprehensive quality assurance protocols. Its product line ranges from vape cartridges and tinctures to capsules and edible preparations, all manufactured under strict Good Manufacturing Practice (GMP) standards.
Headquartered in Victoria, British Columbia, Valens operates multiple Health Canada–licensed processing facilities and maintains strategic partnerships across North America, Europe, and Asia. The company has also engaged in research collaborations in Israel and Germany, positioning it to navigate diverse regulatory landscapes and meet evolving consumer preferences worldwide.
Guided by a management team with extensive backgrounds in pharmaceutical science, analytical testing, and engineering, Valens continues to invest in research and development to refine its extraction technology and expand its product offerings. This emphasis on scientific rigor and scalable production has enabled the company to establish itself as a leading contract manufacturer in the global cannabis industry.
AI Generated. May Contain Errors.